Suchergebnisse - "Breccia, Massimo"

PubPharm (21)

1

First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis

enthalten in: Blood | 2024

von Crespiatico, I. | Zaghi, M. | Mastini, C. | +37

CommentIn: Blood. 2024 Apr 4;143(14):1323-1324. - PMID 38573606

2

A traffic light for TFR by lineage-specific MRD

enthalten in: Blood | 2023

von Breccia, M.

CommentOn: Blood. 2023 Dec 21;142(25):2192-2197. - PMID 37616555

3

Effects and outcome of a policy of intermittent imatinib treatment in elderly patients with chronic myeloid leukemia

enthalten in: Blood | 2013

von Russo, D. | Martinelli, G. | Malagola, M. | +23

ErratumIn: Blood. 2014 May 1;123(18):2902 Bergamaschi, Michela [corrected to Bergamaschi, Micaela]

4

Effects and outcome of a policy of intermittent imatinib treatment in elderly patients with chronic myeloid leukemia

enthalten in: Blood | 2013

von Russo, D. | Martinelli, G. | Malagola, M. | +22

5

The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs : from the perspective of a large group of CML experts

enthalten in: Blood | 2013

von Experts in Chronic Myeloid Leukemia | Abboud, C. | Berman, E. | +98

CommentIn: AMA J Ethics. 2015 Aug;17(8):750-3. - PMID 26270874

6

The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts

enthalten in: Blood | 2013

von Abboud, C. | Berman, E. | Cohen, A. | +96

7

Increased BMI correlates with higher risk of disease relapse and differentiation syndrome in patients with acute promyelocytic leukemia treated with the AIDA protocols

enthalten in: Blood | 2012

von Breccia, M. | Mazzarella, L. | Bagnardi, V. | +11

8

Increased BMI correlates with higher risk of disease relapse and differentiation syndrome in patients with acute promyelocytic leukemia treated with the AIDA protocols

enthalten in: Blood | 2012

von Breccia, M. | Mazzarella, L. | Bagnardi, V. | +11

9

Health-related quality of life in chronic myeloid leukemia patients receiving long-term therapy with imatinib compared with the general population

enthalten in: Blood | 2011

von Efficace, F. | Baccarani, M. | Breccia, M. | +69

CommentIn: Blood. 2011 Oct 27;118(17):4499-500. - PMID 22033940

10

Health-related quality of life in chronic myeloid leukemia patients receiving long-term therapy with imatinib compared with the general population

enthalten in: Blood | 2011

von Efficace, F. | Baccarani, M. | Breccia, M. | +22